Arrowstreet Capital’s Lam Research LRCX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.82B Sell
13,179,818
-169,652
-1% -$37.9M 1.52% 8
2025
Q4
$2.29B Buy
13,349,470
+2,008,605
+18% +$312M 1.34% 8
2025
Q3
$1.52B Buy
11,340,865
+10,053,978
+781% +$1.06B 0.96% 11
2025
Q2
$125M Buy
+1,286,887
New +$102M 0.09% 218
2025
Q1
Sell
-236,860
Closed -$17.1M 1925
2024
Q4
$17.1M Sell
236,860
-6,085,730
-96% -$462M 0.01% 657
2024
Q3
$516M Buy
6,322,590
+402,950
+7% +$35M 0.44% 51
2024
Q2
$630M Buy
5,919,640
+3,553,020
+150% +$341M 0.55% 45
2024
Q1
$230M Buy
2,366,620
+2,352,810
+17,037% +$207M 0.21% 98
2023
Q4
$1.08M Sell
13,810
-73,940
-84% -$5.04M ﹤0.01% 1088
2023
Q3
$5.5M Buy
87,750
+54,720
+166% +$3.59M 0.01% 641
2023
Q2
$2.12M Buy
33,030
+8,540
+35% +$481K ﹤0.01% 809
2023
Q1
$1.3M Buy
+24,490
New +$1.2M ﹤0.01% 999
2022
Q4
Sell
-20,160
Closed -$738K 1404
2022
Q3
$738K Buy
+20,160
New +$897K ﹤0.01% 1042
2021
Q4
Sell
-936,540
Closed -$53.3M 1598
2021
Q3
$53.3M Buy
936,540
+275,450
+42% +$16.8M 0.07% 307
2021
Q2
$43M Sell
661,090
-355,020
-35% -$22.4M 0.05% 364
2021
Q1
$60.5M Buy
1,016,110
+306,710
+43% +$16.7M 0.08% 242
2020
Q4
$33.5M Sell
709,400
-2,770,400
-80% -$117M 0.05% 398
2020
Q3
$115M Buy
3,479,800
+1,966,570
+130% +$67.7M 0.18% 103
2020
Q2
$48.9M Sell
1,513,230
-1,630,250
-52% -$44.5M 0.09% 211
2020
Q1
$75.4M Sell
3,143,480
-8,840,590
-74% -$255M 0.21% 94
2019
Q4
$350M Buy
11,984,070
+3,569,000
+42% +$94.8M 0.81% 22
2019
Q3
$194M Buy
+8,415,070
New +$177M 0.45% 53
2018
Q1
Sell
-7,767,550
Closed -$143M 1242
2017
Q4
$143M Sell
7,767,550
-477,790
-6% -$9.39M 0.34% 77
2017
Q3
$153M Buy
8,245,340
+2,845,900
+53% +$46.2M 0.41% 63
2017
Q2
$76.4M Sell
5,399,440
-486,970
-8% -$7.14M 0.23% 120
2017
Q1
$75.6M Buy
+5,886,410
New +$69.2M 0.28% 88
2016
Q4
Sell
-10,608,090
Closed -$100M 2155
2016
Q3
$100M Buy
10,608,090
+4,191,460
+65% +$38.1M 0.33% 66
2016
Q2
$53.9M Buy
6,416,630
+184,830
+3% +$1.48M 0.18% 137
2016
Q1
$51.5M Buy
6,231,800
+2,142,820
+52% +$15.6M 0.22% 110
2015
Q4
$32.5M Buy
4,088,980
+2,590,980
+173% +$19.5M 0.15% 144
2015
Q3
$9.79M Buy
+1,498,000
New +$11M 0.05% 351
2015
Q2
Sell
-11,450,500
Closed -$80.4M 1238
2015
Q1
$80.4M Buy
11,450,500
+4,571,690
+66% +$36.1M 0.5% 54
2014
Q4
$54.6M Buy
6,878,810
+4,131,820
+150% +$32M 0.31% 75
2014
Q3
$20.5M Buy
+2,746,990
New +$19.6M 0.11% 188
2014
Q2
Sell
-3,021,260
Closed -$16.6M 1096
2014
Q1
$16.6M Sell
3,021,260
-570,790
-16% -$3.03M 0.1% 200
2013
Q4
$19.6M Buy
3,592,050
+2,966,550
+474% +$15.6M 0.11% 190
2013
Q3
$3.2M Sell
625,500
-1,026,750
-62% -$5.02M 0.02% 460
2013
Q2
$7.33M Buy
+1,652,250
New +$7.47M 0.05% 267

Other funds holding LRCX

Arrowstreet Capital's LRCX Position: Q1 2026 in Review

Arrowstreet Capital reduced its Lam Research (LRCX) stake by 1.3% in Q1 2026, selling an estimated $37.9M and leaving 13,179,818 shares worth $2.82B. The position accounts for 1.52% of the portfolio, ranked #8.

Arrowstreet Capital first reported a position in LRCX in Q2 2013 and has held it in 38 quarters since. 2,630 funds tracked by Wall St. Rank hold LRCX as of Q1 2026.

  • Arrowstreet Capital held 13,179,818 shares of Lam Research worth $2.82B as of Q1 2026.
  • Arrowstreet Capital sold 169,652 Lam Research shares in Q1 2026, an estimated $37.9M.
  • Lam Research made up 1.52% of Arrowstreet Capital's portfolio in Q1 2026, its #8 holding.
  • Arrowstreet Capital first reported a position in Lam Research in Q2 2013 and has held it in 38 quarters since.
  • 2,630 funds tracked by Wall St. Rank held Lam Research as of Q1 2026.

Based on Arrowstreet Capital's 13F filing for Q1 2026, filed 14 May 2026.